AI Science Tracker

University of Parma

1 discovery from 2024

Discoveries

Structure-based virtual screening identifies mammalian enzymes catalyzing the second step of carnitine biosynthesis

The OSMES workflow screened AlphaFold-modeled vitamin-B6-dependent enzymes by docking the substrate into active sites and ranking catalytically favorable conformations. It identified human SHMT1/2 as enzymes with hydroxytrimethyllysine-aldolase activity, validated in vitro; mouse Tha1 showed much higher catalytic efficiency, supporting a species difference in the pathway. The authors infer that humans may have lost a dedicated gene, with SHMT activity partly compensating.

Technology: OSMES (One Substrate–Many Enzymes Screening), automated structure-based docking/ranking workflow using AlphaFold models

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: It identified human SHMT1/2 as enzymes with hydroxytrimethyllysine-aldolase activity, validated in vitro; mouse Tha1 showed much higher catalytic efficiency, supporting a species difference in the pathway.
  • Still unknown: Enzyme activity was validated in vitro. The claim about loss of a dedicated human gene is an evolutionary inference, not a direct gene-knockout demonstration; the authors note unresolved pathway questions.
  • AI role: Ranked candidate enzymes for a specified metabolic reaction using docked substrate conformations and catalytically favorable active-site geometry; guided biochemical testing that verified SHMT1/2 activity.

Evidence sources: https://www.nature.com/articles/s41467-024-47466-3.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 87 of works of the same type, year and subfield (OpenAlex work metrics, 13 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.